| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.80B | 14.51B | 13.36B | 11.52B | 11.46B | 15.07B |
| Gross Profit | 10.98B | 14.24B | 7.07B | 5.66B | 7.14B | 8.97B |
| EBITDA | 2.92B | 2.52B | 2.69B | 1.46B | 2.34B | 4.10B |
| Net Income | 762.00M | 602.00M | 1.27B | 517.00M | 1.29B | 2.80B |
Balance Sheet | ||||||
| Total Assets | 109.80B | 109.01B | 95.37B | 80.61B | 65.14B | 60.69B |
| Cash, Cash Equivalents and Short-Term Investments | 56.87B | 32.86B | 31.05B | 26.56B | 37.73B | 36.36B |
| Total Debt | 4.77B | 4.77B | 4.71B | 4.28B | 3.66B | 3.51B |
| Total Liabilities | 101.08B | 100.04B | 86.84B | 73.15B | 58.57B | 51.23B |
| Stockholders Equity | 7.25B | 7.42B | 7.75B | 6.91B | 6.12B | 9.41B |
Cash Flow | ||||||
| Free Cash Flow | 5.82B | 6.38B | 6.67B | 6.35B | 4.22B | 3.96B |
| Operating Cash Flow | 5.95B | 6.52B | 6.82B | 6.48B | 4.36B | 4.09B |
| Investing Cash Flow | -9.46B | -9.63B | -7.86B | -9.09B | -10.52B | -7.45B |
| Financing Cash Flow | 1.49B | 2.26B | 1.76B | 3.09B | 4.09B | 5.00B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
85 Outperform | $5.33B | 7.75 | 12.01% | 1.88% | 1.34% | 2.64% | |
76 Outperform | $12.33B | 12.36 | 17.40% | 1.36% | 9.02% | 53.71% | |
76 Outperform | $5.33B | 7.54 | 14.00% | 1.89% | -1.24% | 4.62% | |
73 Outperform | $6.75B | 9.92 | 12.56% | 3.58% | 27.63% | 328.74% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $12.74B | 16.39 | 9.85% | 3.69% | 13.76% | -30.60% | |
53 Neutral | $8.40B | 32.60 | 20.85% | 0.93% | 18.37% | 98.44% |